KYORIN Pharmaceutical Co., Ltd.

4569・Prime Market・Pharmaceuticals

Official website

KYORIN Pharmaceutical Co., Ltd.

4569・Prime Market・Pharmaceuticals

Official website

KYORIN Pharmaceutical Co., Ltd.4569

Reference Indicators

Market Cap

664¥100M

P/E (Forecast)

—

P/B

0.4x

Dividend Yield (Forecast)

2.26%

ROE

2.5%

EV/EBITDA

9.5x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	105,534	113,270	119,532	130,087	126,257
Cost of Sales	56,093	63,102	68,124	70,551	74,634
Gross Profit	49,441	50,167	51,408	59,535	51,622
SG&A Expenses	44,433	45,043	45,394	46,967	48,055
Operating Income	5,007	5,123	6,013	12,567	3,567
Non-operating Income	677	799	735	870	812
Non-operating Expenses	115	94	146	218	349
Ordinary Income	5,569	5,827	6,602	13,219	4,031
Extraordinary Income	0	1,979	1,404	103	473
Extraordinary Losses	352	900	987	551	53
Pre-tax Income	5,216	6,906	7,019	12,770	4,451
Income Taxes	1,284	2,182	1,696	3,684	1,002
Net Income	3,932	4,723	5,322	9,086	3,448
EBITDA	8,721	8,963	10,303	17,170	8,230
Gross Margin	46.8%	44.3%	43.0%	45.8%	40.9%
Operating Margin	4.7%	4.5%	5.0%	9.7%	2.8%
ROA	2.3%	2.7%	3.0%	4.7%	1.8%
ROE	3.2%	3.8%	4.2%	6.8%	2.5%